Calcipotriol/betamethasone foam for proactive management of plaque psoriasis: four case reports
Psoriasis is a chronic inflammatory disease affecting about 100 million people worldwide. Around 80% of patients can be treated with topical agents, most commonly corticosteroids and vitamin D analogues. A topical foam formulation of calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) (...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
BioExcel Publishing Ltd,
2022-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|